Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giffen, P. S.
Right arrow Articles by York, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giffen, P. S.
Right arrow Articles by York, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 30, No. 3, 365-372 (2002)
DOI: 10.1080/01926230252929945

Alpha-Glutathione S-Transferase in the Assessment of Hepatotoxicity—Its Diagnostic Utility in Comparison with Other Recognized Markers in the Wistar Han Rat

Paul S. Giffen

Clinical Pathology, Cellular and Biochemical Toxicology, Safety Assessment, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom, psg21280@ gsk.com

Chris R. Pick

Department of Pathology, Preclinical Safety Sciences, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom

Mark A. Price

Department of Toxicology, Preclinical Safety Sciences, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom

Ann Williams

Department of Pathology, Preclinical Safety Sciences, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom

Malcolm J. York

Clinical Pathology, Cellular and Biochemical Toxicology, Safety Assessment, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom

The diagnostic utility of alpha-glutathione S-transferase ({alpha}GST) in the assessment of acute hepatotoxicity was compared with a range of markers including alanine aminotransferas e (ALT) and aspartate aminotransferas e (AST). Rats were given a single oral dose of either {alpha}-naphthylisothiocynate (ANIT), bromobenzen e (BrB), or thioacetamide (TAM) at concentrations previously shown to induce marked hepatotoxicity. The progression of each hepatic lesion was monitored by the measurement of a battery of markers, including {alpha}GST, in plasma collected at time points ranging from 3 h to 7 days after dosing. {alpha}GST was seen to increase significantly at 24 h (ANIT/BrB) and 3 h (TAM) postdosing, corresponding with histopathological findings. For each compound, when the degree of insult was most severe, fold increases in {alpha}GST were greater than those seen with ALT and AST, yet lower than those seen with glutamate dehydrogenas e (BrB and ANIT), sorbitol dehydrogenas e (TAM), or total bilirubin and bile acids (ANIT). Elevations in {alpha} GST were also detected no earlier than any other marker. {alpha}GST in the rat was shown to be a valid marker of hepatotoxicity ; however, its measurement offered no additional information in detecting either the time of onset/recovery or the severity of each type of hepatic injury induced.

Key Words: Bromobenzene (BrB) • {alpha}-glutathione S-transferase ({alpha}GST) • hepatic markers • liver enzymes • {alpha}-naphthylisothiocynate (ANIT) • thioacetamide (TAM).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?